Top Markets
#1 Gravity Gravity +75.10%
#2 Galxe Galxe +57.82%
#3 TENDIES TENDIES +36.20%
#4 Railgun Railgun +36.15%
#5 Geodnet Geodnet +24.60%
#6 Fake World Assets Fake World Assets +23.71%
#7 Akedo Akedo +22.61%
#8 Injective Injective +16.93%
#9 Kinetiq Kinetiq +16.68%
#10 Collector Crypt Collector Crypt +16.50%
Coin of the day
Gravity Gravity
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Rang in aandelen #36
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aandeelprijs
$483.81
Marktkapitalisatie
$379.28B
Verandering (1 dag)
0.92%
Verandering (1 jaar)
46.65%
Land
CH
Handel Roche Holding AG (RO)

Categorie

Healthcare
P/S-ratio voor Roche Holding AG (RO)
P/S-ratio op September 2026 TTM: 4.17
Volgens de meest recente financiële rapporten en aandelenkoers van Roche Holding AG is de huidige P/S-ratio (TTM) 4.17. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Roche Holding AG van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.45 222.49%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.55 57.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.18 72.19%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.39 29.18%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
5.52 32.37%
CH